825 related articles for article (PubMed ID: 12028455)
1. Activity and functional significance of the renal kallikrein-kinin-system in polycystic kidney disease of the rat.
Braun C; Kleemann T; Hilgenfeldt U; Riester U; Rohmeiss P; van der Woude FJ
Kidney Int; 2002 Jun; 61(6):2149-56. PubMed ID: 12028455
[TBL] [Abstract][Full Text] [Related]
2. Interactions of the kallikrein-kinin and renin-angiotensin systems in experimental diabetes.
Vora JP; Oyama TT; Thompson MM; Anderson S
Diabetes; 1997 Jan; 46(1):107-12. PubMed ID: 8971089
[TBL] [Abstract][Full Text] [Related]
3. Kinins are involved in the antiproteinuric effect of angiotensin-converting enzyme inhibition in experimental diabetic nephropathy.
Tschöpe C; Seidl U; Reinecke A; Riester U; Graf K; Schultheiss HP; Hilgenfeldt U; Unger T
Int Immunopharmacol; 2003 Mar; 3(3):335-44. PubMed ID: 12639811
[TBL] [Abstract][Full Text] [Related]
4. Chronic kinin blockade and effect of ramipril in renal adaptation to sodium restriction.
Jover B; Hérizi A; Mimran A
Hypertension; 1996 Jan; 27(1):79-84. PubMed ID: 8591893
[TBL] [Abstract][Full Text] [Related]
5. Functional, biochemical, and molecular investigations of renal kallikrein-kinin system in diabetic rats.
Tschöpe C; Reinecke A; Seidl U; Yu M; Gavriluk V; Riester U; Gohlke P; Graf K; Bader M; Hilgenfeldt U; Pesquero JB; Ritz E; Unger T
Am J Physiol; 1999 Dec; 277(6):H2333-40. PubMed ID: 10600853
[TBL] [Abstract][Full Text] [Related]
6. Increased activity of the renal kallikrein-kinin system in autosomal dominant polycystic kidney disease in rats, but not in humans.
Braun C; Kleemann T; Birck R; Hilgenfeldt U; Riester U; Tschöpe C; van der Woude FJ; Rohmeiss P
Int Immunopharmacol; 2002 Dec; 2(13-14):1949-56. PubMed ID: 12489808
[TBL] [Abstract][Full Text] [Related]
7. Possible protective effects of kinins and converting enzyme inhibitors in cardiovascular tissues.
Nolly H; Miatello R; Damiani MT; Abate CD
Immunopharmacology; 1997 Jun; 36(2-3):185-91. PubMed ID: 9228545
[TBL] [Abstract][Full Text] [Related]
8. The renoprotective effect of angiotensin-converting enzyme inhibitors in experimental chronic renal failure is not dependent on enhanced kinin activity.
Nabokov A; Amann K; Gassmann P; Schwarz U; Orth SR; Ritz E
Nephrol Dial Transplant; 1998 Jan; 13(1):173-6. PubMed ID: 9481735
[TBL] [Abstract][Full Text] [Related]
9. The cardioprotective effect of dual metallopeptidase inhibition: respective roles of endogenous kinins and natriuretic peptides.
Dumoulin MJ; Adam A; Burnett J; Heublein D; Yamaguchi N; Lamontagne D
Can J Physiol Pharmacol; 2005 Feb; 83(2):166-73. PubMed ID: 15791290
[TBL] [Abstract][Full Text] [Related]
10. Acute renal excretory actions of losartan in spontaneously hypertensive rats: role of AT2 receptors, prostaglandins, kinins and nitric oxide.
Munoz-Garcia R; Maeso R; Rodrigo E; Navarro J; Ruilope LM; Casal MC; Cachofeiro V; Lahera V
J Hypertens; 1995 Dec; 13(12 Pt 2):1779-84. PubMed ID: 8903651
[TBL] [Abstract][Full Text] [Related]
11. Effect of angiotensin-converting enzyme inhibition on circulating and local kinin levels.
Johnston CI; Clappison BH; Anderson WP; Yasujima M
Am J Cardiol; 1982 Apr; 49(6):1401-4. PubMed ID: 6122371
[TBL] [Abstract][Full Text] [Related]
12. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors.
Liu YH; Yang XP; Sharov VG; Nass O; Sabbah HN; Peterson E; Carretero OA
J Clin Invest; 1997 Apr; 99(8):1926-35. PubMed ID: 9109437
[TBL] [Abstract][Full Text] [Related]
13. Contribution of the renin-angiotensin and kallikrein-kinin systems to short-term variability of blood pressure in two-kidney, one-clip hypertensive rats.
Ponchon P; Elghozi JL
Eur J Pharmacol; 1996 Feb; 297(1-2):61-70. PubMed ID: 8851167
[TBL] [Abstract][Full Text] [Related]
14. Acute renal hemodynamic effects of ACE inhibition in diabetic hyperfiltration: role of kinins.
Komers R; Cooper ME
Am J Physiol; 1995 Apr; 268(4 Pt 2):F588-94. PubMed ID: 7733315
[TBL] [Abstract][Full Text] [Related]
15. Effects of icatibant on the ramipril-induced decreased in renal lithium clearance in the rat.
Bagaté K; Grima M; De Jong W; Imbs JL; Barthelmebs M
Naunyn Schmiedebergs Arch Pharmacol; 2001 Mar; 363(3):281-7. PubMed ID: 11284442
[TBL] [Abstract][Full Text] [Related]
16. [Hormonal contribution to short-term variability of blood pressure in a renovascular hypertension model].
Ponchon P; Elghozi JL
Arch Mal Coeur Vaiss; 1995 Aug; 88(8):1203-7. PubMed ID: 8572874
[TBL] [Abstract][Full Text] [Related]
17. Induction of functional bradykinin b(1)-receptors in normotensive rats and mice under chronic Angiotensin-converting enzyme inhibitor treatment.
Marin-Castaño ME; Schanstra JP; Neau E; Praddaude F; Pecher C; Ader JL; Girolami JP; Bascands JL
Circulation; 2002 Feb; 105(5):627-32. PubMed ID: 11827930
[TBL] [Abstract][Full Text] [Related]
18. Comparison of enalapril and valsartan in cyclosporine A-induced hypertension and nephrotoxicity in spontaneously hypertensive rats on high-sodium diet.
Lassila M; Finckenberg P; Pere AK; Krogerus L; Ahonen J; Vapaatalo H; Nurminen ML
Br J Pharmacol; 2000 Jul; 130(6):1339-47. PubMed ID: 10903974
[TBL] [Abstract][Full Text] [Related]
19. Role of kinins and nitric oxide in the effects of angiotensin converting enzyme inhibitors on neointima formation.
Farhy RD; Carretero OA; Ho KL; Scicli AG
Circ Res; 1993 Jun; 72(6):1202-10. PubMed ID: 7684331
[TBL] [Abstract][Full Text] [Related]
20. Blocking angiotensin II ameliorates proteinuria and glomerular lesions in progressive mesangioproliferative glomerulonephritis.
Nakamura T; Obata J; Kimura H; Ohno S; Yoshida Y; Kawachi H; Shimizu F
Kidney Int; 1999 Mar; 55(3):877-89. PubMed ID: 10027924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
